William Mack & Associates’s Thermo Fisher Scientific TMO Stock Holding History

William Mack & Associates’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$37.8K	Buy	+56	New	+$33.3K	0.01%	274

Other funds holding TMO

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

William Mack & Associates's TMO Position: Q3 2026 in Review

William Mack & Associates opened a new position in Thermo Fisher Scientific (TMO) in Q3 2026: 56 shares worth $37.8K. The stake represents 0.01% of the portfolio and ranks #274 among its holdings.

2,450 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

William Mack & Associates held 56 shares of Thermo Fisher Scientific worth $37.8K as of Q3 2026.
Thermo Fisher Scientific was a new William Mack & Associates position in Q3 2026.
Thermo Fisher Scientific made up 0.01% of William Mack & Associates's portfolio in Q3 2026, its #274 holding.
2,450 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on William Mack & Associates's 13F filing for Q3 2026, filed 27 Oct 2026.